GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer
Condition:   Advanced Endometrial Cancer Interventions:   Drug: Pembrolizumab;   Biological: GEN1046 Sponsors:   Genmab;   BioNTech SE Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
Conditions:   Ovarian Cancer;   Malignant Neoplasm of Uterus Interventions:   Drug: Sacituzumab;   Drug: Cisplatin Sponsor:   Icahn School of Medicine at Mount Sinai Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials